Founded in 2004 by a group of PhD students as a spin-off from the University of Zurich, Molecular Partners AG is a thriving and steadily growing clinical stage biotech company located in Zurich-Schlieren (Switzerland) with 140 highly qualified employees.
In order to advance modern medicine and significantly improve the management of serious diseases, we have developed and successfully established a powerful new class of potent, specific and versatile small protein therapies, called DARPin® therapeutics.
The continuous development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology based on the company’s proprietary DARPin® platform allowed a successful listing of the company on the SIX Swiss Exchange (ticker: MOLN). Next to our own pipeline of drug candidates we have entered into collaborations with leading international pharmaceutical companies, including Allergan, Amgen, Roche and Janssen Pharmaceuticals.
The highly dedicated, multi-disciplined team at MP is committed to developing breakthrough medicines for serious diseases.
As an addition to the Translational Science team we are looking for a motivated Group Leader/Translational Lead. In this challenging role you will be responsible for the following tasks:
Frau Barbara Weber
+41 44 755 57 65